Anna French, PhD, is a partner at Qiming Venture Partners, based in Boston. Prior to joining Qiming Ventures in July 2017, Dr. French was a management consultant at the Boston Consulting Group (BCG) where she advised top 10 global biopharma companies on their strategy and operations. Prior to BCG, Dr. French led a global industry-academic consortium focused on cell therapy commercialization.
Dr. French earned a PhD (D.Phil) from the University of Oxford, UK in Clinical Laboratory Sciences where her research focused on hematological applications of human induced pluripotent stem (iPS) cells. She has a 1st Class BSc. in Biochemistry from the University of Bristol, UK.
Dr. French has over 20 publications in the field of stem cell research, including in Cell Stem Cell, Nature Biotechnology and Trends in Biotechnology. She is an editorial board member for Current Stem Cell Research & Therapy and an invited reviewer for a number of journals.
Prior to joining Optum Ventures, Stephen spent time in Transaction Advisory Services at Ernst and Young, working on projects ranging from large scale M&A to smaller venture-backed startups. He has also spent time as an analyst at both RockPort Capital Partners and Leerink Partners working exclusively with venture-backed companies. Stephen brings strong analytical and financial experience to Optum Ventures. He graduated magna cum laude from Boston College with degrees in Finance and Accounting.
Steve is a Venture Partner at HLM Venture Partners.
Mr. Todd Cozzens is a managing partner at Leernik Transformation Partners. He has more than 25 years of experience in the healthcare technology and information systems industry; focusing on investing in early and growth stage healthcare technology service companies, and advises companies currently under investment. Most recently he was a partner at Sequoia Capital. Prior to joining Sequoia, Cozzens founded, and led, high acuity information system leader Picis, where it was Cozzens’ original strategic vision that drove the company to a 50% annual growth rate over a 10-year span and to over 2,300 hospital clients. Prior to Picis, he held several senior executive positions with Marquette Medical Systems, now GE Healthcare. He is on the board of directors for Health Catalyst, MedExpress, Natera, PerfectServe, Zirmed, and chairs the board of AirStrip and SVBio. Cozzen’s also has recently served in an advisory capacity to Optum, TPG, TelCare, and the Carlyle Group. He is a graduate of Marquette University and the Harvard Business School Executive Program for Management Development.